Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Quantum chemical modeling, molecular docking, and ADMET evaluation of imidazole phenothiazine hybrids.

  • Authors : Shukla D; Department of Chemistry, Integral University, Dasauli, P.O. Bas-ha, Kursi Road, Lucknow, UP, 226026, India.; Azad I

Subjects: Phenothiazines*/Phenothiazines*/Phenothiazines*/chemistry ; Phenothiazines*/Phenothiazines*/Phenothiazines*/pharmacology ; Phenothiazines*/Phenothiazines*/Phenothiazines*/pharmacokinetics

  • Source: Scientific reports [Sci Rep] 2025 Jul 02; Vol. 15 (1), pp. 23413. Date of Electronic Publication: 2025 Jul 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Fabrication and appraisal of axitinib loaded PEGylated spanlastics against MCF- 7 and OV- 2774 cell lines using molecular docking methods and in-vitro study.

  • Authors : Zaki RM; Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.

Subjects: Axitinib*/Axitinib*/Axitinib*/pharmacology ; Axitinib*/Axitinib*/Axitinib*/chemistry ; Polyethylene Glycols*/Polyethylene Glycols*/Polyethylene Glycols*/chemistry

  • Source: PloS one [PLoS One] 2025 Jul 01; Vol. 20 (7), pp. e0325055. Date of Electronic Publication: 2025 Jul 01 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Triazole-imidazo[1,2- b ]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes.

  • Authors : Brullo C; Department of Pharmacy, University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy.; Marengo B

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/pathology ; Melanoma*/Melanoma*/Melanoma*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jun 30; Vol. 26 (13). Date of Electronic Publication: 2025 Jun 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

Antiproliferative Water-Soluble Mono- and Binuclear Ruthenium Complexes with Pyridone-Imidazole Ligands.

  • Authors : Shutkov IA; Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia.; Melnichuk NA

Subjects: Ruthenium*/Ruthenium*/Ruthenium*/chemistry ; Ruthenium*/Ruthenium*/Ruthenium*/pharmacology ; Pyridones*/Pyridones*/Pyridones*/chemistry

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 May 29; Vol. 26 (11). Date of Electronic Publication: 2025 May 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

Design, synthesis, anticancer properties, and molecular docking of imidazolone derivatives with lipophilic moiety.

  • Authors : Fares O; Department of Chemistry, Faculty of Science, An-Najah National University, P.O. Box 7, Nablus, Palestine.; Hamed O

Subjects: Molecular Docking Simulation* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

  • Source: Scientific reports [Sci Rep] 2025 May 27; Vol. 15 (1), pp. 18537. Date of Electronic Publication: 2025 May 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Imidazole Hybrids: A Privileged Class of Heterocycles in Medicinal Chemistry with New Insights into Anticancer Activity.

  • Authors : Murtazaeva Z; Department of Organic Synthesis and Bioorganic Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.; Nasrullaev A

Subjects: Imidazoles*/Imidazoles*/Imidazoles*/chemistry ; Imidazoles*/Imidazoles*/Imidazoles*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry

  • Source: Molecules (Basel, Switzerland) [Molecules] 2025 May 21; Vol. 30 (10). Date of Electronic Publication: 2025 May 21.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

×
Academic Journal

Anti-cancer Effects of 1,4-Dialkoxynaphthalene-Imidazolium Salt Derivatives through ERK5 kinase activity inhibition.

  • Authors : Lee H; Department of Applied Chemistry, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Giheung, Yongin, Gyeonggi-Do, 1732, Republic of Korea.; Nguyen AT

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

  • Source: Scientific reports [Sci Rep] 2025 Apr 20; Vol. 15 (1), pp. 13648. Date of Electronic Publication: 2025 Apr 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus Imatinib.

  • Authors : Ashaye A; Takeda Development Center Americas Inc., Cambridge, Massachusetts, USA.; Shi L

Subjects: Pyridazines*/Pyridazines*/Pyridazines*/therapeutic use ; Pyridazines*/Pyridazines*/Pyridazines*/adverse effects ; Pyridazines*/Pyridazines*/Pyridazines*/administration & dosage

  • Source: Cancer medicine [Cancer Med] 2025 Apr; Vol. 14 (7), pp. e70780.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Cancer Accumulation and Anticancer Activity of "CROX (Cluster Regulation of RUNX)" PIP in HER2-Positive Gastric Cancer Evaluated by Chicken Egg Cancer Model.

  • Authors : Masuda T; Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba, Japan.; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/metabolism ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology

  • Source: Cancer medicine [Cancer Med] 2025 Apr; Vol. 14 (7), pp. e70845.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Broad-spectrum ubiquitin-specific protease inhibition as a mechanism for the cytotoxicity of YM155 in cancers.

  • Authors : Li X; China R&D Center, Cothera Bioscience, Inc., 8 Shengmingyuan Road, 102206, Beijing, China.; He N

Subjects: Imidazoles*/Imidazoles*/Imidazoles*/pharmacology ; Naphthoquinones*/Naphthoquinones*/Naphthoquinones*/pharmacology ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: Scientific reports [Sci Rep] 2025 Apr 01; Vol. 15 (1), pp. 11054. Date of Electronic Publication: 2025 Apr 01.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
  • 1-10 ل  2,214 نتائج ل ""Imidazoles""